Cargando…
Effects of delta-opioid receptor agonist pretreatment on the cardiotoxicity of bupivacaine in rats
BACKGROUND: Delta-opioid receptor is widely expressed in human and rodent hearts, and has been proved to protect cardiomyocytes against ischemia/reperfusion and heart failure. The antagonist of delta-opioid receptor could block the rescue effect of lipid emulsion against local anesthetic cardiotoxic...
Autores principales: | Wang, Chenran, Sun, Shen, Jiao, Jing, Yu, Xinhua, Huang, Shaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753886/ https://www.ncbi.nlm.nih.gov/pubmed/35021986 http://dx.doi.org/10.1186/s12871-022-01568-x |
Ejemplares similares
-
The effects of an insulin-glucose-potassium (IGK) pretreatment on the bupivacaine cardiotoxicity
por: Kim, Jin-Tae, et al.
Publicado: (2013) -
Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia
por: Dripps, Isaac J., et al.
Publicado: (2020) -
Hypocapnia delays subsequent bupivacaine cardiotoxicity in rats under sevoflurane anesthesia
por: Yu, Shuchun, et al.
Publicado: (2014) -
Intralipid fails to rescue bupivacaine-induced cardiotoxicity in late-pregnant rats
por: Sherman, Caitlin, et al.
Publicado: (2022) -
In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists
por: Pradhan, Amynah A. A., et al.
Publicado: (2009)